27 июля 2024 года
Mirati's Charles Baum takes the helm at Terremoto Biosciences dincorvaia Thu, 07/25/2024 - 11:09
AbbVie axes midstage Alzheimer's program amid 'evolving landscape' gmasson Thu, 07/25/2024 - 10:32
Chemomab trumpets liver disease win, but investors retreat ntaylor Thu, 07/25/2024 - 09:35
Viking's obesity med set to charge into phase 3, with $300M earmarked for clinical program aarmstrong Thu, 07/25/2024 - 09:21
Sanofi drops phase 2 dwarfism drug as part of rare disease clear-out jwaldron Thu, 07/25/2024 - 07:05
Roche pumps brakes in Pompe disease, axing gene therapy after assessing competition ntaylor Thu, 07/25/2024 - 06:33
Autobahn Labs partners with Charles River to speed translation of academic research dincorvaia Wed, 07/24/2024 - 11:59
Novartis hopes for better luck with bispecifics via $150M upfront Dren Bio deal dincorvaia Wed, 07/24/2024 - 10:53
Tourette's biotech Asarina to wind down after outreach to 200 companies fails to produce a partner aarmstrong Wed, 07/24/2024 - 09:41
Pfizer’s gene therapy offers alternative to 'burden' of regular infusions, but can it outlast Roctavian? jwaldron Wed, 07/24/2024 - 08:15
